TrialJAMA cardiology2019

Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial.

Barry Greenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.